- RecruitingPHASE3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
This study, called Proact, is investigating a new treatment called REACT (also known as rilparencel) for people with type 2 diabetes and chronic kidney disease. Researchers want to see if this treatment can help kidney function and if it is safe.
For: Type 2 Diabetes Mellitus · Chronic Kidney DiseasesUnited States · Australia · Canada - Not yet recruitingNA
Neuromuscular Electrical Stimulation to Improve the Muscle Health of Individuals With Acute Kidney Injury
This study looks at whether gentle electrical pulses can help protect leg muscles in hospital patients with sudden kidney problems. Staying in bed can cause quick muscle loss. Researchers want to see if this passive muscle exercise helps people keep their strength and recover better after going home.
For: Acute Kidney Injury · Acute Kidney Injury KDIGO 2 · Acute Kidney Injury KDIGO 3United Kingdom - Active not recruitingPHASE3
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
This study is testing a new medicine, zorevunersen, for children and teenagers with Dravet syndrome. We want to see if it can help reduce seizures and improve their overall health, using a safe and gentle approach.
For: Dravet SyndromeUnited States · China · France - RecruitingPHASE1, PHASE2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
This clinical trial tests an experimental one-off eye injection called SAR446597 for adults aged 60 and over with geographic atrophy, an advanced form of dry age-related macular degeneration (AMD). Doctors want to see if the treatment is safe, well tolerated, and helps protect vision over a five-year period.
For: Geographic AtrophyUnited States · Australia · United Kingdom